Latest News in the Life Sciences Industry
PR Newswire Association LLC.
Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis
26 Jun 2026
PR Newswire Association LLC.
Lilly launches "The Memory Radio Station" across Europe, inviting the public to visually reconstruct fading memories through GenAI
26 Jun 2026
GlobeNewswire
Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility
26 Jun 2026
GlobeNewswire
Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
25 Jun 2026
PR Newswire Association LLC.
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities
24 Jun 2026
GlobeNewswire
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
24 Jun 2026
GlobeNewswire
Ichnos Glenmark Innovation (IGI) Announces Appointment of Mariana Cota Stirner, M.D., Ph.D., as Chief Medical Officer
23 Jun 2026
GlobeNewswire
Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
23 Jun 2026
GlobeNewswire
iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
22 Jun 2026
PR Newswire Association LLC.
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting
22 Jun 2026
GlobeNewswire
Boehringer Ingelheim accelerates precision oncology research with initiation of three Phase III trials in hard-to-treat cancers
22 Jun 2026
GlobeNewswire
Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026
22 Jun 2026
GlobeNewswire
MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
21 Jun 2026
PR Newswire Association LLC.
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares
19 Jun 2026
Upcoming Events All Events
- October 2026
- Milan: CPHI Milan 2026
- Basel: 26th Annual Biotech in Europe Forum
- Yokohama: BioJapan